To Evaluate the Epidemiological and Clinical Profile of Pyogenic Liver Abscess
Background: Liver abscess is one of the most important clinical problems. Pyogenic liver abscess (PLA) is defined as a collection of pus surrounded by a fibrous layer of tissue in the liver. The present study was undertaken for evaluating the epidemiological and clinical profile of pyogenic liver abscess.
Materials & Methods: A total of 150 patients presenting with signs and symptoms of liver abscess was enrolled. Thorough clinical examination was carried out and abdominal ultrasonography along with examination of the aspirates was done for confirming the diagnosis. Positive bacterial culture report from the aspirate further confirmed the presence of pyogenic liver abscess. Complete demographic data was recorded in a Performa. Detailed history of all the patients was taken and clinical profile was recorded. A questionnaire was made and epidemiological profile was also recorded.
Results: 28.67 percent of the patients belonged to the age group of more than 60 years. 58 percent of the patients belonged to the lower class while 41.33 percent of the patients belonged to the middle class. 80.67 percent of the patients were males. While assessing the clinical profile, it was seen that fever and pain abdomen was seen in 100 percent of the patients each. Jaundice was seen in 77.33 percent of the patients while diarrhoea was seen in 73.33 percent of the patients. Hepatomegaly was observed 83.33 percent of the patients.
Conclusion: Pyogenic liver abscess mostly manifests in the form of pain abdomen, fever and hepatomegaly and mostly affects subjects of lower socioeconomic state.
2. Tsai FC, Huang YT, Chang LY, Wang JT. Pyogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis. 2008;14:1592–600.
3. Lo JZ, Leow JJ, Ng PL, Lee HQ, Mohd Noor NA, Low JK, Junnarkar SP, Woon WW. Predictors of therapy failure in a series of 741 adult pyogenic liver abscesses. J Hepatobiliary Pancreat Sci. 2015;22:156–65.
4. Mischinger HJ, Hauser H, Rabl H, Quehenberger F, Werkgartner G, Rubin R, Deu E. Pyogenic liver abscess: studies of therapy and analysis of risk factors. World J Surg. 1994;18:852–857.
5. Cerwenka H, Bacher H, Werkgartner G, El-Shabrawi A, Kornprat P, Bernhardt GA, Mischinger HJ. Treatment of patients with pyogenic liver abscess. Chemotherapy. 2005;51:366–9.
6. Stanley Jr. S.L. Amoebiasis. The Lancet. 2003; 361:1025-34.
7. Haque R, Duggal P, Ali IM, Hossain MB, Mondal D, Sack RB et al. Innate and acquired resistance to Amebiasis in Bangladeshi children. J Infect Dis.2002;186:547-52
8. Channanna C, Rehman FU, Choudhuri B, Patil A. A clinical study, diagnosis and management of Liver Abscess at VIMS, Bellary. .Journal of Evidence Based Medicine and Health Care 2014; 1:668-85.
9. Lok KH et al. Pyogenic liver abscess: clinical profile, microbiological characteristics, and management in a Hong Kong hospital. J Microbiol Immunol Infect. 2008 Dec;41(6):483-90.
10. Abbas MT, Khan FY, Muhsin SA, Al-Dehwe B, Abukamar M, Elzouki AN. Epidemiology, Clinical Features and Outcome of Liver Abscess: A single Reference Center Experience in Qatar. Oman Med J. 2014;29(4):260-263.
11. Kong H, Yu F, Zhang W, Li X. Clinical and microbiological characteristics of pyogenic liver abscess in a tertiary hospital in East China. Medicine (Baltimore). 2017;96(37):e8050.
Copyright (c) 2020 Somen Jha, Kumar Ratnesh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.